General Information of the Compound
Compound ID
CP0430482
Compound Name
2-p-Tolyl-2H,5H-[1,2,4]triazolo[4,3-a]quinoxaline-1,4-dione
    Show/Hide
Structure
Formula
C16H12N4O2
Molecular Weight
292.298
Canonical SMILES
Cc1ccc(cc1)-n1nc2n(c3ccccc3[nH]c2=O)c1=O
    Show/Hide
InChI
InChI=1S/C16H12N4O2/c1-10-6-8-11(9-7-10)20-16(22)19-13-5-3-2-4-12(13)17-15(21)14(19)18-20/h2-9H,1H3,(H,17,21)
    Show/Hide
InChIKey
XHVPSVUOSSODBL-UHFFFAOYSA-N
Physicochemical Property
logP
1.63512
Rotatable Bonds
1
Heavy Atom Count
22
Polar Areas
72.16
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10803557
SID: 15843251
ChEMBL ID
CHEMBL279410
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 25 nM
   TI
   LI
   LO
   TS